Comparative analysis of cefoperazone-sulbactam and piperacillin-tazobactam in empirical treatment of acute biliary tract infections: a multicenter, retrospective, real-world study

Abstract Patients diagnosed with acute cholecystitis or cholangitis admitted to three tertiary Grade A hospitals between January 2022 and March 2026 were enrolled. All subjects were divided into the cefoperazone-sulbactam group and piperacillin-tazobactam group according to the initial empirical ant...

Полное описание

Библиографические подробности

Главные авторы:	Lixing Yang, Zhouye Song, Dayu Chen, Nan Zhou, Peng Zhang, Lu Cao
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Nature Portfolio 2026-07-01
Серии:	Scientific Reports
Предметы:	Cefoperazone-sulbactam Piperacillin-tazobactam Acute biliary tract infections Empirical treatment Real-world study
Online-ссылка:	https://doi.org/10.1038/s41598-026-63210-x
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!